ARS Pharmaceuticals, Inc. (SPRY)
4.30
-0.26
(-5.70%)
USD |
NASDAQ |
Oct 09, 12:57
ARS Pharmaceuticals 30-Day Average Daily Volume : 1.454M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.454M |
| October 07, 2026 | 1.440M |
| October 06, 2026 | 1.454M |
| October 05, 2026 | 1.478M |
| October 02, 2026 | 1.466M |
| October 01, 2026 | 1.475M |
| September 30, 2026 | 1.450M |
| September 29, 2026 | 1.472M |
| September 28, 2026 | 1.513M |
| September 25, 2026 | 1.649M |
| September 24, 2026 | 1.681M |
| September 23, 2026 | 1.689M |
| September 22, 2026 | 1.689M |
| September 21, 2026 | 1.691M |
| September 18, 2026 | 1.723M |
| September 17, 2026 | 1.702M |
| September 16, 2026 | 1.724M |
| September 15, 2026 | 1.740M |
| September 14, 2026 | 1.719M |
| September 11, 2026 | 1.716M |
| September 10, 2026 | 1.685M |
| September 09, 2026 | 1.863M |
| September 08, 2026 | 1.879M |
| September 04, 2026 | 1.903M |
| September 03, 2026 | 1.991M |
| Date | Value |
|---|---|
| September 02, 2026 | 2.044M |
| September 01, 2026 | 2.108M |
| August 31, 2026 | 2.225M |
| August 28, 2026 | 2.257M |
| August 27, 2026 | 2.288M |
| August 26, 2026 | 2.291M |
| August 25, 2026 | 2.314M |
| August 24, 2026 | 2.320M |
| August 21, 2026 | 2.302M |
| August 20, 2026 | 2.307M |
| August 19, 2026 | 2.275M |
| August 18, 2026 | 2.302M |
| August 17, 2026 | 2.278M |
| August 14, 2026 | 2.232M |
| August 13, 2026 | 2.124M |
| August 12, 2026 | 2.096M |
| August 11, 2026 | 2.097M |
| August 10, 2026 | 2.099M |
| August 07, 2026 | 2.222M |
| August 06, 2026 | 2.419M |
| August 05, 2026 | 2.442M |
| August 04, 2026 | 2.400M |
| August 03, 2026 | 2.423M |
| July 31, 2026 | 2.427M |
| July 30, 2026 | 2.392M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Capricor Therapeutics, Inc. | 4.152M |
| Sionna Therapeutics, Inc. | 1.356M |
| Nektar Therapeutics | 1.542M |
| Vertex Pharmaceuticals, Inc. | 1.013M |
| Ardelyx, Inc. | 4.292M |